Incruse Ellipta and Posaconazole Delayed-Release Tablets
Determining the interaction of Incruse Ellipta and Posaconazole Delayed-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: umeclidinium
Brand name: Incruse Ellipta
Synonyms: n.a.
Generic Name: posaconazole
Brand name: Noxafil
Synonyms: Posaconazole (oral/injection), Posaconazole
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Incruse Ellipta-Posaconazole Injection
- Incruse Ellipta-Posaconazole Intravenous
- Incruse Ellipta-Posaconazole Oral Suspension
- Incruse Ellipta-Posaconazole oral/injection
- Incruse Ellipta-Posaconazole Tablets
- Incruse Ellipta-PosiFlush flush
- Posaconazole Delayed-Release Tablets-Indacaterol
- Posaconazole Delayed-Release Tablets-Indacaterol and Glycopyrrolate
- Posaconazole Delayed-Release Tablets-Indacaterol and glycopyrrolate Inhalation
- Posaconazole Delayed-Release Tablets-Indacaterol inhalation
- Posaconazole Delayed-Release Tablets-Indacaterol Maleate
- Posaconazole Delayed-Release Tablets-Indapamide